Literature DB >> 20307406

Professional continuous glucose monitoring in clinical practice 2010.

Thomas C Blevins1.   

Abstract

Professional continuous glucose monitoring (PCGM) is a 3-5 day test done to evaluate diabetes control. The PCGM test uses interstitial glucose measurements done every 5 min with a glucose-oxidase-impregnated membrane. The PCGM test evaluates glucose control retrospectively with the glucose results being unknown to the patient until the results are downloaded after the testing period. The PCGM test allows the practitioner and patient to evaluate the effect of diet, physical activity, medications, and lifestyle events on glucose control during the 24 h period. Developing a PCGM program at a medical office involves understanding reimbursement issues and having trained staff and a process in place to initiate the test and download and interpret the data. (c) 2010 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307406      PMCID: PMC2864181          DOI: 10.1177/193229681000400226

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  7 in total

1.  Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.

Authors:  Robert Tanenberg; Bruce Bode; Wendy Lane; Claresa Levetan; Jorge Mestman; Anne Peters Harmel; Janet Tobian; Todd Gross; John Mastrototaro
Journal:  Mayo Clin Proc       Date:  2004-12       Impact factor: 7.616

2.  A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.

Authors:  F R Kaufman; L C Gibson; M Halvorson; S Carpenter; L K Fisher; P Pitukcheewanont
Journal:  Diabetes Care       Date:  2001-12       Impact factor: 19.112

3.  The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control.

Authors:  Ana Chico; Pablo Vidal-Ríos; Montserrat Subirà; Anna Novials
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

4.  Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.

Authors:  E Boland; T Monsod; M Delucia; C A Brandt; S Fernando; W V Tamborlane
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

5.  The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk.

Authors:  R Schiaffini; P Ciampalini; A Fierabracci; S Spera; P Borrelli; G F Bottazzo; A Crinò
Journal:  Diabetes Metab Res Rev       Date:  2002 Jul-Aug       Impact factor: 4.876

6.  Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study.

Authors:  Johnny Ludvigsson; Ragnar Hanas
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

7.  Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial.

Authors:  Helen R Murphy; Gerry Rayman; Karen Lewis; Susan Kelly; Balroop Johal; Katherine Duffield; Duncan Fowler; Peter J Campbell; Rosemary C Temple
Journal:  BMJ       Date:  2008-09-25
  7 in total
  11 in total

1.  Is the masked continuous glucose monitoring system clinically useful for predicting hemoglobin A1C in type 1 diabetes?

Authors:  Elizabeth Duran-Valdez; Mark R Burge; Paula Broderick; Lynda Shey; Virginia Valentine; Ronald Schrader; David S Schade
Journal:  Diabetes Technol Ther       Date:  2014-05       Impact factor: 6.118

2.  Professional continuous glucose monitoring in subjects with type 1 diabetes: retrospective hypoglycemia detection.

Authors:  Morten Hasselstrøm Jensen; Toke Folke Christensen; Lise Tarnow; Zeinab Mahmoudi; Mette Dencker Johansen; Ole Kristian Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

Review 3.  Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes.

Authors:  Nalani Haviland; John Walsh; Ruth Roberts; Timothy S Bailey
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 4.  Utility of different glycemic control metrics for optimizing management of diabetes.

Authors:  Klaus-Dieter Kohnert; Peter Heinke; Lutz Vogt; Eckhard Salzsieder
Journal:  World J Diabetes       Date:  2015-02-15

5.  Influence of oral antidiabetic drugs on hyperglycemic response to foods in persons with type 2 diabetes mellitus as assessed by continuous glucose monitoring system: a pilot study.

Authors:  Peterson Karolina; Rudolf Chlup; Zapletalova Jana; Klaus Dieter Kohnert; Pavla Kudlova; Josef Bartek; Marie Nakladalova; Blanka Doubravova; Pavel Seckar
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

6.  The Evolving Role of Short-Term Professional Continuous Glucose Monitoring on Glycemic Control and Hypoglycemia Among Saudi Patients with Type 1 Diabetes: A Prospective Study.

Authors:  Ayman A Al Hayek; Asirvatham A Robert; Mohammed Al Dawish; Rania A Ahmed; Fahad S Al Sabaan
Journal:  Diabetes Ther       Date:  2015-07-05       Impact factor: 2.945

7.  Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.

Authors:  Louise Hyltén-Cavallius; Eva W Iepsen; Nicolai J Wewer Albrechtsen; Mathilde Svendstrup; Anniek F Lubberding; Bolette Hartmann; Thomas Jespersen; Allan Linneberg; Michael Christiansen; Henrik Vestergaard; Oluf Pedersen; Jens J Holst; Jørgen K Kanters; Torben Hansen; Signe S Torekov
Journal:  Circulation       Date:  2017-02-24       Impact factor: 29.690

8.  Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.

Authors:  Natsuyo Hariya; Kazuki Mochizuki; Seiya Inoue; Miyoko Saito; Masahiro Fuchigami; Toshinao Goda; Takeshi Osonoi
Journal:  Drugs R D       Date:  2014-09

Review 9.  An Overview of Insulin Pumps and Glucose Sensors for the Generalist.

Authors:  Brooke H McAdams; Ali A Rizvi
Journal:  J Clin Med       Date:  2016-01-04       Impact factor: 4.241

10.  Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes.

Authors:  Rogelio U Almario; Wendy M Buchan; David M Rocke; Sidika E Karakas
Journal:  BMJ Open Diabetes Res Care       Date:  2017-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.